Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F de Groot

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2011
High-dose antiangiogenic therapy for glioblastoma: less may be more?John F de Groot
Continuum (Minneapolis, Minn.)|April 4, 2015
High-grade gliomasJohn F de Groot
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Prediction of response to chemotherapy in anaplastic glioma: how many markers does it take?John F de Groot
Neuro-Oncology|November 13, 2018
Lower-grade gliomas: the wrong target for bevacizumabDavid Schiff, John F de Groot
Current Opinion in Neurology|November 10, 2007
New molecular targets in malignant gliomasJohn F de Groot, Mark R Gilbert
Current Oncology Reports|February 11, 2014
Update on anti-angiogenic treatment for malignant gliomasJohn F de Groot, Jacob J Mandel
JAMA Oncology|May 18, 2023
External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With GlioblastomaJacob J Mandel, John F de Groot
Drugs & Aging|July 25, 2018
Treatment of Glioblastoma in the ElderlyRebecca A Harrison, John F de Groot
Journal of Oncology Practice|October 12, 2017
Treatment of GlioblastomaJoo Yeon Nam, John F de Groot
Topics in Magnetic Resonance Imaging : TMRI|January 13, 2017
Cell Signaling Pathways in Brain TumorsRebecca A Harrison, John F de Groot
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2011
High-dose antiangiogenic therapy for glioblastoma: less may be more?John F de Groot
Continuum (Minneapolis, Minn.)|April 4, 2015
High-grade gliomasJohn F de Groot
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Prediction of response to chemotherapy in anaplastic glioma: how many markers does it take?John F de Groot
Neuro-Oncology|November 13, 2018
Lower-grade gliomas: the wrong target for bevacizumabDavid Schiff, John F de Groot
Current Opinion in Neurology|November 10, 2007
New molecular targets in malignant gliomasJohn F de Groot, Mark R Gilbert
Current Oncology Reports|February 11, 2014
Update on anti-angiogenic treatment for malignant gliomasJohn F de Groot, Jacob J Mandel
JAMA Oncology|May 18, 2023
External Control Arms and Data Analysis Methods in Nonrandomized Trial of Patients With GlioblastomaJacob J Mandel, John F de Groot
Drugs & Aging|July 25, 2018
Treatment of Glioblastoma in the ElderlyRebecca A Harrison, John F de Groot
Journal of Oncology Practice|October 12, 2017
Treatment of GlioblastomaJoo Yeon Nam, John F de Groot
Topics in Magnetic Resonance Imaging : TMRI|January 13, 2017
Cell Signaling Pathways in Brain TumorsRebecca A Harrison, John F de Groot
Pageof 13